Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

3 Predictions for Next Week: Ebix Inc (EBIX), Krispy Kreme Doughnuts (KKD)

Page 1 of 2

I went out on a limb last week, and now it’s time to see how that decision played out.

I predicted that Ferrellgas Partners, L.P. (NYSE:FGP) would move higher on the week. The leading propane distributor was set to report earnings, and a strong report to back its hefty yield should’ve kept the units moving higher. The units closed 0.5% higher after accounting for its latest $0.50-per-unit distribution. It wasn’t enough to beat the market, but the prediction was merely about a positive return on the week. I was right.

Ebix Inc (NASDAQ:EBIX)I predicted that the tech-heavy Nasdaq would outperform the Dow Jones Industrial Average. . This has been a tricky call lately, so how did it play out this time? It was a strong week for the markets, and while all of the attention seems to be on the Dow’s hitting an all-time high, secondary stocks weren’t exactly slouches. The Nasdaq closed 2.4% higher. The Dow, on the other hand, managed to clock in with a gain of 2.2% on the week. I was right.

My final call was for Main Street Capital Corporation (NYSE:MAIN) to beat Wall Street’s quarterly profit target. The business development company is rolling, blowing through Wall Street’s bottom-line forecasts with ease over the past year. Analysts were looking for a profit of $0.49 a share during the quarter, and Main Street Capital came through with net income of $0.56. I was right.

Three out of three? Awesome!

Let me once again whip out my trusty, dusty, and occasionally accurate crystal ball to make three calls that may play out over the next few trading days.

1.Krispy Kreme will shoot higher on the week
Krispy Kreme Doughnuts (NYSE:KKD) has been as sweet as its doughy treats these days. The stock hit an eight-year this past week. One has to go all the way back to the summer of 2004 to find the last time the stock was trading this high.

Things can get even better this new week. Krispy Kreme Doughnuts (NYSE:KKD) reports on Thursday. Analysts see profitability doubling to $0.12 a share, but it’s easy to expect even more. Wall Street has erred on the conservative side here lately, as Krispy Kreme Doughnuts (NYSE:KKD) has beaten profit projections by 50% or better in the past three quarters.

A strong report should send the sugary shares off to new highs. My first call is for Krispy Kreme Doughnuts (NYSE:KKD) to close the week higher.

2.The Nasdaq Composite will beat the Dow this week
Tech has been a big winner in recent years, so betting on tech over stodgy blue chips has been a good bet for me more often than not. I’m going to stick with this pick. Most of the names in the composite are just too cheap at this point, and the results this earnings season weren’t as bad as some worrywarts had feared.

The market is ripe for the tech-stacked secondary stocks to continue to outpace the 30 megacaps that make up the Dow Jones Industrial Average.

3. Ebix Inc (NASDAQ:EBIX) will beat Wall Street’s earnings estimates
Some stocks are just flat-out better than others.

When it comes to providing enterprise software solutions, Ebix Inc (NASDAQ:EBIX) has been a strong performer. Shares took a hit last month after a bearish report criticized the company’s accounting practices, but Ebix started to bounce back after defending itself and its bean counting.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!